Gene · 4174
Papers2,000
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,000
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway. | Biomedicines | 2022 | 36009559 | PubTator, text mining | PubMed |
| The PNA mouse may be the best animal model of polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2022 | 36004354 | PubTator, text mining | PubMed |
| Identification of Human Cell Cycle Phase Markers Based on Single-Cell RNA-Seq Data by Using Machine Learning Methods. | Biomed Res Int | 2022 | 36004205 | PubTator, text mining | PubMed |
| Revealing the intratumoral heterogeneity of non-DS acute megakaryoblastic leukemia in single-cell resolution. | Front Oncol | 2022 | 36003795 | PubTator, text mining | PubMed |
| Integrated single-cell RNA-seq and DNA methylation reveal the effects of air pollution in patients with recurrent spontaneous abortion. | Clin Epigenetics | 2022 | 35999615 | PubTator, text mining | PubMed |
| KLF4 recruits SWI/SNF to increase chromatin accessibility and reprogram the endothelial enhancer landscape under laminar shear stress. | Nat Commun | 2022 | 35999210 | PubTator, text mining | PubMed |
| Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma. | Front Oncol | 2022 | 35978835 | PubTator, text mining | PubMed |
| Predict the Progression of Cervical Intraepithelial Neoplasia by a Novel Marker Folate Combine with FRα, p16 and Ki-67. | Int J Gen Med | 2022 | 35971526 | PubTator, text mining | PubMed |
| A Liquid Biopsy in Bladder Cancer-The Current Landscape in Urinary Biomarkers. | Int J Mol Sci | 2022 | 35955727 | PubTator, text mining | PubMed |
| The Role of Novel Bladder Cancer Diagnostic and Surveillance Biomarkers-What Should a Urologist Really Know? | Int J Environ Res Public Health | 2022 | 35955004 | PubTator, text mining | PubMed |
| DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective. | Cancers (Basel) | 2022 | 35954483 | PubTator, text mining | PubMed |
| CHIKV infection reprograms codon optimality to favor viral RNA translation by altering the tRNA epitranscriptome. | Nat Commun | 2022 | 35953468 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis. | Cell Biosci | 2022 | 35941699 | PubTator, text mining | PubMed |
| Measuring the contributions of helicases to break-induced replication. | Methods Enzymol | 2022 | 35934483 | PubTator, text mining | PubMed |
| Optimizing CMG helicase and CMG-dependent replication assays by designing DNA fork substrates and choosing nucleotide analogues for helicase preloading. | Methods Enzymol | 2022 | 35934475 | PubTator, text mining | PubMed |
| A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes. | Front Immunol | 2022 | 35924232 | PubTator, text mining | PubMed |
| Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence. | Stem Cells Int | 2022 | 35910534 | PubTator, text mining | PubMed |
| Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis. | BMC Oral Health | 2022 | 35906577 | PubTator, text mining | PubMed |
| Mapping subcellular localizations of unannotated microproteins and alternative proteins with MicroID. | Mol Cell | 2022 | 35905735 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4174/papers?page=16